ITGR · Earnings event · Q2 2026 · archived
Integer Holdings (ITGR) Q2 2026 earnings — TrendMatrix coverage
Reported · EPS $1.60 vs estimate $1.38 (+15.8%) — classified BEAT.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
EPS beat/miss and revenue
| Metric | Estimate | Actual | Surprise |
|---|---|---|---|
| EPS (diluted) | $1.38 | $1.60 | +15.8% |
| Revenue | — | — | — |
Verdict reaction
How the verdict moved around this report
Before this report, TrendMatrix rated ITGR Hold at 5.1/10. After the Q2 2026 report, the verdict moved to Sell at 5.1/10.
Healthcare context
ITGR at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $4.25B
- P/E (fwd)
- 18.2
- P/E (ttm)
- 34.3
- 52-week range
- $62.00–$126.14
- Off 52-week high
- 0.7%
- RSI (14)
- 94
- Volume vs avg
- 0.23×
- Engine score
- 4.3/10
Live context at TrendMatrix’s latest engine read — updates after the report date; not frozen to it.